Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Capturing dynamic processes of change in GROW mutual help groups for mental health.

Finn LD, Bishop BJ, Sparrow N.

Am J Community Psychol. 2009 Dec;44(3-4):302-15. doi: 10.1007/s10464-009-9265-5. Review.

PMID:
19915975
2.

Barriers to participation of Aboriginal people in cancer care: communication in the hospital setting.

Shahid S, Finn LD, Thompson SC.

Med J Aust. 2009 May 18;190(10):574-9.

PMID:
19450207
3.

Mutual help groups: an important gateway to wellbeing and mental health.

Finn LD, Bishop B, Sparrow NH.

Aust Health Rev. 2007 May;31(2):246-55.

PMID:
17470046
4.

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU.

Clin Cancer Res. 2001 May;7(5):1198-203.

5.

Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.

Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ.

Cancer. 1997 Dec 1;80(11):2128-32.

PMID:
9392335
6.

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ.

J Clin Oncol. 1995 Sep;13(9):2272-7.

PMID:
7666085

Supplemental Content

Support Center